Prognostic and immunological landscape of DDX17 in pan-cancer analysis: a comprehensive study
These findings indicated that DDX17 may be considered a potential prognostic biomarker and a promising target for novel immunotherapeutic approaches in cancer treatment.
Authors
- Peng Chen (ORCID: https://orcid.org/0000-0002-8484-9356)
- Lei Yu (ORCID: https://orcid.org/0000-0003-1707-4885)
- Yan Liu (ORCID: https://orcid.org/0000-0003-1490-8602)
- Pu Li (ORCID: https://orcid.org/0000-0002-9152-3143)
- Xin He (ORCID: https://orcid.org/0000-0003-1178-4413)
- Xing Wei (ORCID: https://orcid.org/0000-0002-3035-5633)
- Bin Ge (ORCID: https://orcid.org/0000-0002-1491-2364)
- Yi-Ping Qin
Institutions
- Chongqing University (CN)
- Chongqing Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1007/s12672-025-02955-9
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chengdu Medical College
- Natural Science Foundation of Chongqing
- Centre Scientifique et Technique du Bâtiment
- Natural Science Foundation of Sichuan Province
- Health Commission of Sichuan Province
- Bijzonder Onderzoeksfonds UGent